Charles Sigal

Charles Sigal

Director/Board Member at VIR BIOTECHNOLOGY, INC.

Net worth: 610 487 $ as of 30/05/2024

72 year
Health Technology
Commercial Services
Health Services

Profile

Charles Elliott Sigal is currently serving as a Director at Medarex, Inc. He is also an Independent Director at Alnylam Pharmaceuticals, Inc., Vir Biotechnology, Inc., Affinia Therapeutics, Inc., and Tessera Therapeutics, Inc. Additionally, he holds positions as a Member of the Drug Discovery & Development Forum at the National Academy of Medicine (United States) and a Member of the President Council at The J.
David Gladstone Institutes.
Dr. Sigal is a Trustee at University Medical Center and manages Segal Family Investments LLC.
In his former roles, Dr. Sigal served as the Chief Executive Officer and Vice President of R&D at Mercator Genetics, Inc. He was also the Director, Chief Scientific Officer, and Executive VP at Bristol Myers Squibb Co. from 2011 to 2013.
Additionally, he held the position of Director at Mead Johnson Nutrition Co. from 2012 to 2017.
Dr. Sigal served as an Independent Director at Spark Therapeutics, Inc. from 2014 to 2019 and as an Independent Non-Executive Director at Surface Oncology, Inc. from 2018 to 2023.
He also served as an Independent Non-Executive Director at Adaptimmune Therapeutics Plc from 2015 to 2023.
Furthermore, Dr. Sigal was a Non-Executive Director at Adaptimmune Ltd.Dr. Sigal obtained his doctorate degree from The University of Chicago in 1981.
He pursued his graduate studies at Purdue University and completed his undergraduate and second doctorate degrees there in 1973 and 1977, respectively.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
15/05/2024 2,000 ( 0.00% ) 296 860 $ 30/05/2024
29/05/2024 23,806 ( 0.02% ) 244 488 $ 30/05/2024
02/07/2023 367,038 ( 0.06% ) 69 139 $ 30/05/2024

Charles Sigal active positions

CompaniesPositionStart
VIR BIOTECHNOLOGY, INC. Director/Board Member 01/07/2020
ALNYLAM PHARMACEUTICALS, INC. Director/Board Member 21/08/2022
Melanoma Research Alliance Director/Board Member 31/10/2013
Director/Board Member 14/06/2021
Director/Board Member 07/06/2020
Segal Family Investments LLC Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
Director/Board Member -
░░░░░░░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
All active positions of Charles Sigal

Former positions of Charles Sigal

CompaniesPositionEnd
░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
See the detail of Charles Sigal's experience

Training of Charles Sigal

The University of Chicago Doctorate Degree
Purdue University Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Charles Sigal's experience

Connections

98

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies4
BRISTOL-MYERS SQUIBB COMPANY

Health Technology

ADAPTIMMUNE THERAPEUTICS PLC

Health Technology

VIR BIOTECHNOLOGY, INC.

Health Technology

ALNYLAM PHARMACEUTICALS, INC.

Health Technology

Private companies14

Consumer Non-Durables

Health Services

Health Services

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Health Technology

Melanoma Research Alliance

Miscellaneous

Health Services

Segal Family Investments LLC

Health Technology

Health Technology

Health Technology

See company connections